Thrombin generation potential is enhanced in systemic sclerosis: impact of selected endothelial biomarkers-Reference-Cited by-同舟云学术

Thrombin generation potential is enhanced in systemic sclerosis: impact of selected endothelial biomarkers

Published:2021-07-28 Issue:4 Volume:39 Page:13-19
ISSN:1593-098X
Container-title:Clinical and Experimental Rheumatology
language:en
Short-container-title:

Author:

Kuszmiersz Piotr¹,Pacholczak-Madej Renata²,Siwiec Angelika¹,Celińska-Lowenhoff Magdalena³,Iwaniec Teresa³,Kosałka-Węgiel Joanna⁴,Zaręba Lech⁵,Bazan-Socha Stanisława³,Dropiński Jerzy⁶

Affiliation:

1. Rheumatology and Immunology Clinic, University Hospital, Cracow, Poland.

2. Department of Anatomy, Jagiellonian University Medical College, Cracow, and National Cancer Institute, Maria Skłodowska-Curie Memorial Institute, Kraków Branch, Poland.

3. Department of Internal Medicine, Jagiellonian University Medical College, Cracow, Poland.

4. Rheumatology and Immunology Clinic, University Hospital, Cracow, and Department of Rheumatology and Balneology, Jagiellonian University Medical College, Cracow, Poland.

5. Interdisciplinary Centre for Computational Modeling, University of Rzeszow, Poland.

6. Department of Internal Medicine, Jagiellonian University Medical College, Cracow, Poland. jerzy.dropinski@uj.edu.pl

Publisher

Clinical and Experimental Rheumatology

Subject

Immunology,Immunology and Allergy,Rheumatology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum IL-17 and TNFα as prognostic biomarkers in systemic sclerosis patients: a prospective study;Rheumatology International;2023-12-05

2. A journey to vasculopathy in systemic sclerosis: focus on haemostasis and thrombosis;Clinical and Experimental Medicine;2023-11-01

3. Increased oxidative stress response in circulating blood of systemic sclerosis patients – relation to disease characteristics and inflammatory blood biomarkers;Seminars in Arthritis and Rheumatism;2023-10

4. Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis;Journal of Inflammation Research;2023-10

5. A randomized clinical trial of bermekimab treatment for clinical improvement of systemic sclerosis;iScience;2023-09